| REGISTERED NUMBER: |
| Invisible Ink SPMU, Medical & Removal |
| Ltd |
| Unaudited Financial Statements |
| for the Year Ended 31 March 2026 |
| REGISTERED NUMBER: |
| Invisible Ink SPMU, Medical & Removal |
| Ltd |
| Unaudited Financial Statements |
| for the Year Ended 31 March 2026 |
| Invisible Ink SPMU, Medical & Removal |
| Ltd (Registered number: 14740155) |
| Contents of the Financial Statements |
| for the Year Ended 31 March 2026 |
| Page |
| Company information | 1 |
| Balance sheet | 2 |
| Notes to the financial statements | 4 |
| Invisible Ink SPMU, Medical & Removal |
| Ltd |
| Company Information |
| for the Year Ended 31 March 2026 |
| Director: |
| Registered office: |
| Registered number: |
| Accountants: |
| Chartered Accountants |
| Construction House, Runwell Road |
| Wickford |
| Essex |
| SS11 7HQ |
| Invisible Ink SPMU, Medical & Removal |
| Ltd (Registered number: 14740155) |
| Balance Sheet |
| 31 March 2026 |
| 2026 | 2025 |
| Notes | £ | £ |
| Current assets |
| Debtors | 4 |
| Cash at bank |
| Creditors |
| Amounts falling due within one year | 5 |
| Net current liabilities | ( |
) | ( |
) |
| Total assets less current liabilities | ( |
) | ( |
) |
| Capital and reserves |
| Called up share capital |
| Retained earnings | ( |
) | ( |
) |
| ( |
) | ( |
) |
| The director acknowledges her responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| Invisible Ink SPMU, Medical & Removal |
| Ltd (Registered number: 14740155) |
| Balance Sheet - continued |
| 31 March 2026 |
| The financial statements were approved by the director and authorised for issue on |
| Invisible Ink SPMU, Medical & Removal |
| Ltd (Registered number: 14740155) |
| Notes to the Financial Statements |
| for the Year Ended 31 March 2026 |
| 1. | Statutory information |
| Invisible Ink SPMU, Medical & Removal Ltd is a |
| 2. | Accounting policies |
| Basis of preparing the financial statements |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Taxation |
| Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Debtors |
| Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment. |
| Cash and cash equivalents |
| Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. |
| Invisible Ink SPMU, Medical & Removal |
| Ltd (Registered number: 14740155) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 2. | Accounting policies - continued |
| Creditors |
| Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method. |
| Financial Instruments |
| The company has elected to apply the provisions of Section 11 "Basic Financial Instruments" of FRS 102 to all of its financial instruments. |
| Financial instruments are recognised in the company's Balance sheet when the company becomes party to the contractual provisions of the instrument. |
| Basic financial assets |
| Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. |
| Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments. |
| Impairment of financial assets |
| Financial assets are assessed for indicators of impairment at each reporting date. |
| Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate. |
| If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss. |
| Financial liabilities |
| Invisible Ink SPMU, Medical & Removal |
| Ltd (Registered number: 14740155) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 2. | Accounting policies - continued |
| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities. |
| Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial. |
| Debt instruments are subsequently carried at their amortised cost using the effective interest rate method. |
| Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial. |
| Derecognition of financial instruments |
| Derecognition of financial assets |
| Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the company will continue to recognise the value of the portion of the risks and rewards retained. |
| Derecognition of financial liabilities |
| Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled. |
| 3. | Employees and directors |
| The average number of employees during the year was |
| 4. | Debtors: amounts falling due within one year |
| 2026 | 2025 |
| £ | £ |
| Prepayments and accrued income |
| Invisible Ink SPMU, Medical & Removal |
| Ltd (Registered number: 14740155) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2026 |
| 5. | Creditors: amounts falling due within one year |
| 2026 | 2025 |
| £ | £ |
| Trade creditors |
| Director's loan account | 4,572 | 4,324 |
| Accruals and deferred income |